These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 2828693)
21. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase. Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186 [TBL] [Abstract][Full Text] [Related]
22. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma. Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046 [TBL] [Abstract][Full Text] [Related]
23. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. Franz WM; Berger P; Wang JY EMBO J; 1989 Jan; 8(1):137-47. PubMed ID: 2496972 [TBL] [Abstract][Full Text] [Related]
24. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA. Srinivasan A; Reddy EP; Aaronson SA Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2077-81. PubMed ID: 6264461 [TBL] [Abstract][Full Text] [Related]
25. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas. Poirier Y; Jolicoeur P J Virol; 1989 May; 63(5):2088-98. PubMed ID: 2539505 [TBL] [Abstract][Full Text] [Related]
26. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. Prywes R; Foulkes JG; Baltimore D J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108 [TBL] [Abstract][Full Text] [Related]
27. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Prywes R; Foulkes JG; Rosenberg N; Baltimore D Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890 [TBL] [Abstract][Full Text] [Related]
28. Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues. Wang JY; Queen C; Baltimore D J Biol Chem; 1982 Nov; 257(22):13181-4. PubMed ID: 6292177 [TBL] [Abstract][Full Text] [Related]
29. Transformation of NIH3T3 cells by A-MuLV proviral DNA: effect of plasmid linearization and carrier DNA on transformation efficiency. Shore SK; Reddy EP Oncogene; 1989 Nov; 4(11):1411-3. PubMed ID: 2554240 [TBL] [Abstract][Full Text] [Related]
30. Properties of a murine retroviral recombinant of avian acute leukemia virus E26: a murine fibroblast assay for v-ets function. Yuan CC; Kan N; Dunn KJ; Papas TS; Blair DG J Virol; 1989 Jan; 63(1):205-15. PubMed ID: 2535727 [TBL] [Abstract][Full Text] [Related]
31. Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements. Even J; Anderson SJ; Hampe A; Galibert F; Lowy D; Khoury G; Sherr CJ J Virol; 1983 Mar; 45(3):1004-16. PubMed ID: 6300443 [TBL] [Abstract][Full Text] [Related]
32. Isolation and characterization of flat revertant cell lines from A-MuLV-transformed fibroblasts. Glass DJ; Rees-Jones RW; Goff SP Oncogene Res; 1990; 5(3):175-85. PubMed ID: 2157187 [TBL] [Abstract][Full Text] [Related]
35. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog. Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233 [TBL] [Abstract][Full Text] [Related]
36. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar. Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498 [TBL] [Abstract][Full Text] [Related]
37. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. Wang JY; Baltimore D J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223 [TBL] [Abstract][Full Text] [Related]
38. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells. Schiff-Maker L; Rosenberg N Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782 [TBL] [Abstract][Full Text] [Related]
39. Recurring proviral integration suggests a role for proto-oncogene activation in thymomas induced with Mo-MuLV-rescued BCR/ABL virus. Clark SS Leukemia; 1997 Jul; 11(7):1026-33. PubMed ID: 9204986 [TBL] [Abstract][Full Text] [Related]
40. Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity. Reynolds FH; Van de Ven WJ; Stephenson JR J Virol; 1980 Nov; 36(2):374-86. PubMed ID: 6253663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]